RABGGTA

Across TCGA pan-cancer cohorts, RABGGTA mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated RABGGTA data layer compared with 19 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RABGGTA mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RABGGTA expression acts as an unfavorable survival marker, although some lineages such as UCEC and OV show a favorable association.

UCEC, OV, and CCRCC are the cancer types where RABGGTA mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	1.000	0.449	.010	24	view →
OV	DFS	Median	All	1.000	0.853	.030	12	view →
CCRCC	DFS	Quartile	All	0.507	0.856	.008	6	view →
HNSC	OS	Median	All	1.000	0.449	.023	6	view →
LUAD	OS	Tertile	All	0.605	0.871	.009	6	view →
LSCC	DFS	Median	III,IV	0.942	0.611	.036	5	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RABGGTA–UCEC (OS)

Open the UCEC breakdown →